- Directory
- April 2024
Global
€2359EUR$2,439USD£1,998GBP
- Training
- December 2023
- 2 Days
Global
From €2804EUR$2,900USD£2,375GBP
- Report
- February 2024
- 150 Pages
Global
From €4110EUR$4,250USD£3,481GBP
- Training
- February 2024
- 2 Days
Global
From €2804EUR$2,900USD£2,375GBP
- Training
- December 2023
- 2 Days
Global
From €1544EUR$1,597USD£1,308GBP
- Training
- July 2024
- 2 Days
Global
From €1540EUR$1,593USD£1,305GBP
- Training
- April 2024
- 3 Days
Global
From €1544EUR$1,597USD£1,308GBP
- Training
- January 2024
- 2 Days
Global
From €2804EUR$2,900USD£2,375GBP
- Training
- January 2024
- 2 Days
Global
From €1544EUR$1,597USD£1,308GBP
- Training
- November 2023
- 2 Days
Global
€3566EUR$3,688USD£3,020GBP
- Training
- September 2023
- 3 Days
Global
From €2804EUR$2,900USD£2,375GBP
- Training
- September 2023
- 3 Days
Global
From €1782EUR$1,843USD£1,509GBP
- Webinar
- April 2022
- 90 Minutes
Global
- Webinar
- July 2023
- 90 Minutes
Global
From €344EUR$355USD£291GBP
- Training
- April 2023
- 2 Days
Global
From €1068EUR$1,105USD£905GBP
- Webinar
- December 2022
- 90 Minutes
Global
- Webinar
- June 2022
- 90 Minutes
Global
- Webinar
- September 2021
- 90 Minutes
Global
- Webinar
- December 2019
- 3 Hours
Global
From €329EUR$340USD£278GBP
- Webinar
- April 2019
- 90 Minutes
Global
The FDA Compliance market within the context of Drug Discovery is a highly regulated industry that requires companies to adhere to strict guidelines in order to bring new drugs to market. Companies must ensure that their products meet the safety and efficacy standards set by the FDA, as well as comply with the Good Manufacturing Practices (GMP) regulations. Companies must also ensure that their products are properly labeled and packaged, and that they are properly stored and transported. Additionally, companies must ensure that their products are properly tested and monitored throughout the drug development process.
Companies in the FDA Compliance market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more